• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interpretation of the 7th edition of the "diagnosis and treatment guidelines of coronavirus disease 2019 in China": Progress and challenges.

作者信息

Xie Li-Xin

机构信息

Center of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, 100853, China.

出版信息

Chronic Dis Transl Med. 2020 Apr 23;6(2):75-78. doi: 10.1016/j.cdtm.2020.04.001. eCollection 2020 Jun.

DOI:10.1016/j.cdtm.2020.04.001
PMID:32328337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7177117/
Abstract
摘要

相似文献

1
Interpretation of the 7th edition of the "diagnosis and treatment guidelines of coronavirus disease 2019 in China": Progress and challenges.《新型冠状病毒肺炎诊疗方案（试行第七版）》解读：进展与挑战
Chronic Dis Transl Med. 2020 Apr 23;6(2):75-78. doi: 10.1016/j.cdtm.2020.04.001. eCollection 2020 Jun.
2
Diagnosis and treatment of emergency surgeries in otorhinolaryngology, head and neck surgery during the covid-19 outbreak: A single center experience.2019冠状病毒病疫情期间耳鼻咽喉头颈外科急诊手术的诊断与治疗：单中心经验
World J Otorhinolaryngol Head Neck Surg. 2020 Nov;6(Suppl 1):S16-S21. doi: 10.1016/j.wjorl.2020.05.002. Epub 2020 May 19.
3
[Chinese experts' consensus on diagnosis and treatment of severe and critical coronavirus disease 2019 (revised edition)].《新型冠状病毒肺炎重型、危重型病例诊疗中国专家共识（修订版）》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):269-274. doi: 10.3760/cma.j.cn121430-20200218-00188.
4
Antiviral therapy for coronavirus disease 2019.2019冠状病毒病的抗病毒治疗
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):598-602. doi: 10.11817/j.issn.1672-7347.2020.200211.
5
[Recommendations for normalizing the medical practices of burn treatment during the outbreak of coronavirus disease 2019].[关于2019冠状病毒病疫情期间规范烧伤治疗医疗行为的建议]
Zhonghua Shao Shang Za Zhi. 2020 Jun 20;36(6):465-469. doi: 10.3760/cma.j.cn501120-20200224-00083.
6
[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].[2019冠状病毒病及严重急性呼吸综合征冠状病毒2的诊断、治疗、控制与预防：回归未来]
Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):571-592. doi: 10.13345/j.cjb.200115.
7
[What are the highlights of "Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team"].《新型冠状病毒感染疾病诊疗（适用于军队支援湖北医疗队）2019》的亮点有哪些？
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Apr 12;43(4):315-320. doi: 10.3760/cma.j.cn112147-20200225-00183.
8
Drug treatment of coronavirus disease 2019 (COVID-19) in China.中国对 2019 冠状病毒病（COVID-19）的药物治疗。
Eur J Pharmacol. 2020 Sep 15;883:173326. doi: 10.1016/j.ejphar.2020.173326. Epub 2020 Jun 27.
9
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.在重症 2019 冠状病毒病患者中，可检测到的血清严重急性呼吸综合征冠状病毒 2 病毒载量（RNAemia）与显著升高的白细胞介素 6 水平密切相关。
Clin Infect Dis. 2020 Nov 5;71(8):1937-1942. doi: 10.1093/cid/ciaa449.
10
Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition).儿童新型冠状病毒肺炎诊疗和预防相关问题专家共识（第二版简化版）
World J Pediatr. 2020 Jun;16(3):232-239. doi: 10.1007/s12519-020-00362-4. Epub 2020 Apr 24.

引用本文的文献

1
The predictive significance of uric acid to high density lipoprotein- cholesterol ratio and uric acid for the severity and mortality of coronavirus disease-19.尿酸与高密度脂蛋白胆固醇比值及尿酸对新型冠状病毒肺炎严重程度和死亡率的预测意义。
BMC Res Notes. 2024 Sep 27;17(1):277. doi: 10.1186/s13104-024-06807-7.
2
Investigation on anxiety and depression of different populations in the area with low incidence of New Coronavirus pneumonia and analysis of related factors.新型冠状病毒肺炎低发地区不同人群焦虑抑郁状况调查及相关因素分析
Pak J Med Sci. 2023 Mar-Apr;39(2):380-384. doi: 10.12669/pjms.39.2.7136.
3
Immune responses in mildly versus critically ill COVID-19 patients.轻症与重症 COVID-19 患者的免疫反应。
Front Immunol. 2023 Jan 30;14:1077236. doi: 10.3389/fimmu.2023.1077236. eCollection 2023.
4
Exploring the mechanism of action of Xuanfei Baidu granule (XFBD) in the treatment of COVID-19 based on molecular docking and molecular dynamics.基于分子对接和分子动力学探索宣肺败毒颗粒治疗新型冠状病毒肺炎的作用机制
Front Cell Infect Microbiol. 2022 Aug 10;12:965273. doi: 10.3389/fcimb.2022.965273. eCollection 2022.
5
Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking.基于网络药理学和分子对接技术的小檗碱治疗新型冠状病毒肺炎肺纤维化机制的研究
Phytomed Plus. 2022 May;2(2):100252. doi: 10.1016/j.phyplu.2022.100252. Epub 2022 Mar 4.
6
Summary report of seven cases of COVID-19 infection in renal transplant recipients.COVID-19 感染肾移植受者 7 例总结报告。
Transpl Immunol. 2021 Dec;69:101445. doi: 10.1016/j.trim.2021.101445. Epub 2021 Aug 10.
7
A patient with end-stage renal disease who recovered from coronavirus disease 2019 then received a kidney transplant.一名终末期肾病患者从2019冠状病毒病中康复后接受了肾脏移植。
Transpl Immunol. 2021 Aug;67:101395. doi: 10.1016/j.trim.2021.101395. Epub 2021 Apr 22.
8
A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.中国 2 家中心回顾性研究：血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂在高血压合并 COVID-19 患者中的持续使用效果。
Med Sci Monit. 2020 Sep 24;26:e926651. doi: 10.12659/MSM.926651.

本文引用的文献

1
[Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].《2019冠状病毒病成人呼吸康复建议》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Apr 12;43(4):308-314. doi: 10.3760/cma.j.cn112147-20200228-00206.
2
[Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team].[《2019新型冠状病毒感染疾病的诊断与治疗——适用于军队支援湖北医疗队》]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Apr 12;43(4):285-287. doi: 10.3760/cma.j.cn112147-20200224-00172.
3
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
4
[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].《2019新型冠状病毒肺炎患者使用糖皮质激素的专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):183-184. doi: 10.3760/cma.j.issn.1001-0939.2020.03.008.
5
Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China.中国无症状儿童粪便标本中新型冠状病毒的 RT-PCR 检测。
Emerg Infect Dis. 2020 Jun;26(6):1337-1339. doi: 10.3201/eid2606.200301. Epub 2020 Jun 17.
6
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
7
Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China.中国武汉以外地区 13 例新型冠状病毒感染的流行病学和临床特征。
JAMA. 2020 Mar 17;323(11):1092-1093. doi: 10.1001/jama.2020.1623.
8
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.